http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-H0948765-A
Outgoing Links
Predicate | Object |
---|---|
assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_75a4811e7eae15e0f1e32cc6a222ce30 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D249-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-41 |
filingDate | 1995-08-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_46cd4961aad834244392bc0ad6584001 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d70e27dae6e48bb1bbcd1f9f73bab930 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_51b4fd4b5ab470f1f2ee26545f7c0b2c http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d0e879029ddecb53aac2223bacb4f523 |
publicationDate | 1997-02-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | JP-H0948765-A |
titleOfInvention | Triazole derivative having stable crystal structure and method for producing the same |
abstract | (57) Abstract: X-ray diffraction using Cu-Kα ray of the present invention shows characteristic peaks at 2θ = 12.48 °, 16.96 ° and 21.08 ° (-)-3- (2,4). -Difluorophenyl) -2,2-difluoro-3-hydroxy-4- (1 The crystals of (H-1,2,4-triazol-1-yl) butanamide are different from the conventionally obtained crystals in that they have good stability against temperature and humidity, and can be produced in large quantities. It is useful as a drug substance. By X-ray diffraction using Cu-Kα rays, 2 (−)-3- (2,4-) which has a stable crystal structure with characteristic peaks at θ = 12.48 °, 16.96 ° and 21.08 °. Difluorophenyl) -2,2-difluoro-3-hydroxy-4- (1H-1,2,4-triazol-1-yl) butanamide [Effect] The crystalline compound of the present invention is different from the conventionally obtained crystals. In contrast, it has good stability against temperature and humidity, can be manufactured in large quantities, and is useful as a drug substance for antifungal agents. |
isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-4789383-B2 |
priorityDate | 1995-08-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 41.